Annexon, Inc.ANNXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-63.5%
5Y CAGR-38.7%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-63.5%/yr
Annual compound
5Y CAGR
-38.7%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 5.00% |
| 2023 | 1.12% |
| 2022 | 12.43% |
| 2021 | 103.09% |
| 2020 | 100.91% |
| 2019 | 57.93% |
| 2018 | -13.02% |
| 2017 | 0.00% |